PLAA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.526800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.583600E-01
Normal-vs-Stage2
4.339000E-01
Normal-vs-Stage3
7.217800E-02
Normal-vs-Stage4
6.886200E-01
Stage1-vs-Stage2
7.900400E-01
Stage1-vs-Stage3
1.501590E-01
Stage1-vs-Stage4
2.274800E-01
Stage2-vs-Stage3
3.151400E-01
Stage2-vs-Stage4
1.866050E-01
Stage3-vs-Stage4
3.716000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.266200E-01
Normal-vs-AfricanAmerican
9.616600E-01
Normal-vs-Asian
1.901160E-01
Caucasian-vs-AfricanAmerican
2.337000E-01
Caucasian-vs-Asian
4.045000E-01
AfricanAmerican-vs-Asian
1.532240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.101800E-01
Normal-vs-Female
3.687200E-01
Male-vs-Female
8.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.783640E-01
Normal-vs-Age(41-60Yrs)
5.870800E-01
Normal-vs-Age(61-80Yrs)
4.199800E-01
Normal-vs-Age(81-100Yrs)
4.043800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.820300E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.770000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.528000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.717800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.728200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.078400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.113760E-01
Normal-vs-Daily Drinker
2.533800E-01
Normal-vs-Weekly Drinker
4.037000E-01
Normal-vs-Occasional Drinker
6.761600E-01
Normal-vs-Social Drinker
7.092400E-01
Non Drinker-vs-Daily Drinker
8.382200E-01
Non Drinker-vs-Weekly Drinker
5.461200E-01
Non Drinker-vs-Occasional Drinker
1.754840E-01
Non Drinker-vs-Social Drinker
7.796500E-02
Daily Drinker-vs-Weekly Drinker
7.276000E-01
Daily Drinker-vs-Occasional Drinker
2.668200E-01
Daily Drinker-vs-Social Drinker
1.957630E-01
Weekly Drinker-vs-Occasional Drinker
5.230600E-01
Weekly Drinker-vs-Social Drinker
4.224200E-01
Occasional Drinker-vs-Social Drinker
8.803400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.575400E-01
Normal-vs-Grade 2
8.811600E-01
Normal-vs-Grade 3
8.415800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.164600E-01
Grade 1-vs-Grade 3
1.720790E-01
Grade 1-vs-Grade 4
9.575400E-01
Grade 2-vs-Grade 3
5.047200E-01
Grade 2-vs-Grade 4
8.811600E-01
Grade 3-vs-Grade 4
8.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.987200E-01
Normal-vs-NonDiabetic
3.895800E-01
Diabetic-vs-NonDiabetic
4.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.377970E-01
Normal-vs-NoPancreatitis
4.630200E-01
Pancreatitis-vs-NoPancreatitis
4.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.919400E-01
Normal-vs-N1
3.791000E-01
N0-vs-N1
1.599970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.255200E-01
Normal-vs-TP53-NonMutant
4.959000E-01
TP53-Mutant-vs-TP53-NonMutant
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
